Atlas Trials

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

Clinical trial NCT04076748 · TERMINATED

Trial details

NCT number
NCT04076748
Sponsor
University Hospital, Bordeaux
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell Crisis
Start date
2021-07-20
Primary completion
2024-07-21
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.